Palisades Investment Partners’s Itron ITRI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.91M Buy
79,808
+574
+0.7% +$49K 1.96% 21
2026
Q1
$7.1M Buy
79,234
+4,228
+6% +$406K 2.78% 12
2025
Q4
$6.97M Buy
75,006
+1,359
+2% +$148K 2.63% 11
2025
Q3
$9.17M Buy
73,647
+84
+0.1% +$10.7K 3.6% 5
2025
Q2
$9.68M Buy
+73,563
New +$8.32M 4.23% 5

Other funds holding ITRI

Palisades Investment Partners's ITRI Position: Q2 2026 in Review

Palisades Investment Partners increased its Itron (ITRI) stake by 0.72% in Q2 2026, buying an estimated $49K and bringing the position to 79,808 shares worth $6.91M. The position accounts for 1.96% of the portfolio, ranked #21.

Palisades Investment Partners first reported a position in ITRI in Q2 2025 and has held it in 5 quarters since. The position peaked at $9.68M in Q2 2025. 137 funds tracked by Wall St. Rank hold ITRI as of Q2 2026.

  • Palisades Investment Partners held 79,808 shares of Itron worth $6.91M as of Q2 2026.
  • Palisades Investment Partners bought 574 Itron shares in Q2 2026, an estimated $49K.
  • Itron made up 1.96% of Palisades Investment Partners's portfolio in Q2 2026, its #21 holding.
  • Palisades Investment Partners first reported a position in Itron in Q2 2025 and has held it in 5 quarters since.
  • Palisades Investment Partners's Itron position peaked at $9.68M in Q2 2025.
  • 137 funds tracked by Wall St. Rank held Itron as of Q2 2026.

Based on Palisades Investment Partners's 13F filing for Q2 2026, filed 4 Aug 2026.